GE HealthCare Technologies GEHC PDx — Total Costs & Expenses

Similar metrics at other companies

OMERPDE7 — Total Costs & Expenses

$575K+4.5%

CAHPharmaceutical and Specialty Solutions — Total Costs & Expenses

$55.33B+11.2%

TBRGPatient Care — Total Costs & Expenses

$24.19M+0.2%

RIGLTotal costs & expenses

$46.93M+15.7%

BCRXTotal costs & expenses

$858.01M+590%

CRNXTotal costs & expenses

$151.11M+35.2%

Questions, answered.

What is GE HealthCare Technologies's pdx — total costs & expenses?

GE HealthCare Technologies (GEHC) reported pdx — total costs & expenses of $573M in Q1 2026.

How has GE HealthCare Technologies's pdx — total costs & expenses changed year-over-year?

GE HealthCare Technologies's pdx — total costs & expenses increased by 33.9% year-over-year, from $428M to $573M.

What is the long-term trend for GE HealthCare Technologies's pdx — total costs & expenses?

Over 3 years (2022 to 2025), GE HealthCare Technologies's pdx — total costs & expenses has grown at a 12.2% compound annual growth rate (CAGR), from $1.44B to $2.03B.

What does pdx — total costs & expenses mean?

The aggregate of all operating costs, including cost of sales, research and development, and selling, general, and administrative expenses attributable to the Pharmaceutical Diagnostics segment. It provides a comprehensive view of the total resource consumption required to operate the segment.